Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses

• প্রধান লেখক: Xi Chen (লেখক), Xiaohui Pan (লেখক), Wenxin Zhang (লেখক), Hongjie Guo (লেখক), Shuyuan Cheng (লেখক), Qiaojun He (লেখক), Bo Yang (লেখক), Ling Ding (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Elsevier, 2020-05-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Immunotherapy strategies targeting the programmed cell death ligand 1 (PD-L1)/programmed cell death 1 (PD-1) pathway in clinical treatments have achieved remarkable success in treating multiple types of cancer. However, owing to the heterogeneity of tumors and individual immune systems, PD-L1/PD-1 b...